Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation

Journal of Surgical Oncology

Volumn 100, Issue 1, 2009, Pages 25-31

  Turaka, Aruna ^a   Freedman, Gary M ^a   Li, Tianyu ^a   Anderson, Penny R ^a   Swaby, Ramona ^a   Nicolaou, Nicos ^a   Goldstein, Lori ^a   Sigurdson, Elin R ^a   Bleicher, Richard J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; DCIS; Radiation therapy; Young age

Indexed keywords

TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; AGE; BREAST TUMOR; CARCINOMA IN SITU; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 67649403396     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21284     Document Type: Article

References (43)

1. Jemal A, Murray T, Samuels A, et al.: Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Ernster VL, Barclay J, Kerlikowske K, et al.: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-918. (Pubitemid 26095381)
3. Sumner WE III, Koniaris LG, Snell SE, et al.: Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol 2007;14:1638-1643. (Pubitemid 46791002)
4. Freedman GM, Anderson PR, Goldstein LJ, et al.: Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer 2003;98:918-925. (Pubitemid 37022090)
5. Tabar L, Chen HH, Fagerberg G, et al.: Recent results from the Swedish Two-County Trial: The effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997;22:43-47.
6. Bleicher RJ, Abrahamse P, Hawley ST, et al.: The influence of age on the breast surgery decision-making process. Ann Surg Oncol 2008;15:854-862.
7. Baxter NN, Virnig BA, Durham SB, et al.: Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-448. (Pubitemid 38443647)
8. Morrow M, White J, Moughan J, et al.: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001;19:2254-2262. (Pubitemid 32366978)
9. Fisher ER, Leeming R, Anderson S, et al.: Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators. J Surg Oncol 1991;47:139-147.
10. Fisher B, Dignam J, Wolmark N, et al.: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993-2000. (Pubitemid 29271743)
11. Yen TW, Kuerer HM, Ottesen RA, et al.: Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol 2007;25:3251-3258. (Pubitemid 47325609)
12. Yen TW, Hunt KK, Mirza NQ, et al.: Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 2004;100:942-949. (Pubitemid 38222854)
13. Leonard GD, Swain SM: Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004;96:906-920. (Pubitemid 38868137)
14. Silverstein MJ: The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003;186:337-343. (Pubitemid 38368606)
15. Bijker N, Peterse JL, Duchateau L, et al.: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-2271. (Pubitemid 32366979)
16. Sahoo S, Recant WM, Jaskowiak N, et al.: Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Breast J 2005;11:242-247. (Pubitemid 41026037)
17. Bijker N, Peterse JL, Duchateau L, et al.: Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001;84:539-544. (Pubitemid 32215883)
18. Silverstein MJ, Lagios MD, Craig PH, et al.: A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274. (Pubitemid 26162419)
19. Fowble B, Hanlon AL, Fein DA, et al.: Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997;38:949-957. (Pubitemid 27353673)
20. Vicini FA, Kestin LL, Goldstein NS, et al.: Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol 2000;18:296-306. (Pubitemid 30056418)
21. Solin LJ, Fourquet A, Vicini FA, et al.: Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: Long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001;50:991-1002. (Pubitemid 32594839)
22. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, et al.: Breast-conserving therapy for ductal carcinoma in situ of the breast: The French Cancer Centers' experience. Int J Radiat Oncol Biol Phys 2002;53:868-879. (Pubitemid 34722631)
23. Fisher ER, Dignam J, Tan-Chiu E, et al.: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: Intraductal carcinoma. Cancer 1999;86:429-438. (Pubitemid 29347405)
24. Bijker N, Meijnen P, Peterse JL, et al.: Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in- situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381-3387. (Pubitemid 46638893)
25. Vicini FA, Recht A: Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: A critical review of the literature. J Clin Oncol 2002;20:2736-2744. (Pubitemid 34575647)
26. Omlin A, Amichetti M, Azria D, et al.: Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006;7:652-656. (Pubitemid 44143777)
27. American Joint Committee on Cancer. Part VII. Breast. In: Greene FL, Balch CM, Page DL, et al.: editors. AJCC cancer staging manual. 6th edition. New York: Springer; 2002. pp. 257-282.
28. Rakovitch E, Franssen E, Kim J, et al.: A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 2003;77:285-293. (Pubitemid 36197643)
29. Winchester DP, Jeske JM, Goldschmidt RA: The diagnosis and management of ductal carcinoma in-situ of the breast. CA Cancer J Clin 2000;50:184-200. (Pubitemid 30417327)
30. Fisher B, Dignam J, Wolmark N, et al.: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-452. (Pubitemid 28135585)
31. Houghton J, George WD, Cuzick J, et al.: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 2003;362:95-102.
32. Smith GL, Smith BD, Haffty BG: Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 2006;65:1397-1403. (Pubitemid 44425216)
33. Van Zee KJ, Liberman L, Samli B, et al.: Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: The effect of age. Cancer 1999;86:1757-1767. (Pubitemid 29513045)
34. Jhingran A, Kim JS, Buchholz TA, et al.: Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2002;54:804-809.
35. Di Saverio S, Catena F, Santini D, et al.: 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: A retrospective review with long term follow up. Breast Cancer Res Treat 2008;109:405-416. (Pubitemid 351692055)
36. Taghian A, Mohiuddin M, Jagsi R, et al.: Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey. Ann. Surg 2005;241:629-639. (Pubitemid 40397311)
37. Kepple J, Henry-Tillman RS, Klimberg VS, et al.: The receptor expression pattern in ductal carcinoma in situ predicts recurrence. Am J Surg 2006;192:68-71. (Pubitemid 43870050)
38. Nakhlis F, Lazarus L, Hou N, et al.: Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma. J Am Coll Surg 2005;201:688-694. (Pubitemid 41539760)
39. Hird RB, Chang A, Cimmino V, et al.: Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ. Cancer 2006;106:2113-2118. (Pubitemid 43673231)
40. Goldhirsch A, Wood WC, Gelber RD, et al.: Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003;21:3357-3365. (Pubitemid 46606270)
41. Fisher B, Costantino JP, Wickerham DL, et al.: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388. (Pubitemid 28439961)
42. Szelei-Stevens KA, Kuske RR, Yantsos VA, et al.: The influence of young age and positive family history of breast cancer on the prognosis of DCIS treated by excision with or without radiation therapy or by mastectomy. Int J Rad Oncol Biol Phys 2000;48:943-949. (Pubitemid 30802130)
43. Rodrigues NA, Dillon D, Carter D, et al.: Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer 2003;97:1393-1403. (Pubitemid 36297768)